TaiGen Biopharmaceuticals Holdings Balance Sheet Health
Financial Health criteria checks 6/6
TaiGen Biopharmaceuticals Holdings has a total shareholder equity of NT$1.1B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.2B and NT$108.9M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.06b |
| Equity | NT$1.11b |
| Total liabilities | NT$108.94m |
| Total assets | NT$1.22b |
Financial Position Analysis
Short Term Liabilities: 4157's short term assets (NT$1.1B) exceed its short term liabilities (NT$58.4M).
Long Term Liabilities: 4157's short term assets (NT$1.1B) exceed its long term liabilities (NT$50.6M).
Debt to Equity History and Analysis
Debt Level: 4157 is debt free.
Reducing Debt: 4157 had no debt 5 years ago.
Debt Coverage: 4157 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4157 has no debt, therefore coverage of interest payments is not a concern.